Growing advancements in antibody engineering are responsible for expansion of antibody discovery market size. The biopharmaceutical industry that has been focusing on biologics is investing heavily in antibody research services. Rise in partnerships between academic institutions and industry players enable sharing of resources, thereby accelerating the discovery of antibodies.
The key players in antibody discovery market are collaborating with the high-tech companies in order to use generative AI to produce foundation models for development of therapeutic antibodies.
They are working toward combining clinical developments and data science expertise to integrate ML technologies with high-speed wet lab. The desired outcome is high-quality antibodies for multiple therapeutic targets.
Antibodies are evolving into one of the versatile classes of biopharmaceuticals, which are undergoing notable advancements with respect to their engineering, discovery methods, and diversification of formats. As per the National Institute of Health, 162 antibody therapies are approved by atleast one regulatory agency as of June 30, 2022.
The complexities associated with monoclonal antibodies discovery are prompting various organizations to utilize and license specialized antibody technologies and platforms.
However, discovering antibodies involves various complexities that may affect the manufacturing capacity and efficiency of antibody therapeutics. For instance, bacterial systems are likely to synthesize inactive proteins, which can result in formation of inclusion bodies.
Moreover, bacteria can do away with signal peptides but not the preproteins such as native coagulation growth factors that can’t be broken. These factors may restrain the antibody discovery market during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Antibody engineering is one of the specialized fields that emphasizes modification of antibodies in order to improve their therapeutic properties. The benefits of antibody engineering include personalization of therapeutic indications and the targeted effects related to this personalization.
The antibody engineering techniques used to produce antibody fragments include single B-cell technology, phage display, hybridoma technology, and also transgenic animals.
The latest advancements include Wacker’s ESETEC secretion technology for obtaining expression post secretion of antibody fragments (Fab) exceeding 4.0 g/L and scFv that exceeds 3.5 g/L into fermentation broth.
Pelican Expression Technology Platform and pOP prokaryotic expression vector are the other platforms meant to create an ample of antibody fragments.
Advantages of antibody engineering such as proper folding of antibodies coupled with essential modifications like glycosylation is one of the major aspects pertaining to discovery of antibodies.
The advancements mentioned above provide a better resolution of the expressions used for producing antibodies, thereby speeding up their discovery.
Need to combat targeted diseases at a faster pace is thus boosting the antibody discovery market revenue.
The key players in the global antibody discovery industry are emphasizing collaborative approach, which helps them in leveraging the manufacturing and research capabilities along with professional expertise of each other. This approach helps in reducing the overheads coupled with fast-tracking the discovery of antibodies.
Along these lines mentioned above, AstraZeneca, since July 2023, is engaged in an open-label, phase II study in collaboration with University Health Network (Toronto) with the objective of assessing efficacy of AZD2936 with respect to molecular residual disease (MRD) clearance and outcome in the patients after administering AXD2936 post definitive treatment for high-risk locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC).
In January 2023, Ono Pharmaceutical Co., Ltd. announced that it had inked an option and research collaboration agreement with Monash University in order to discover as well as develop antibodies that are targeting G protein-coupled receptors (GPCRs). The major objective was to create new therapeutics to treat inflammatory and autoimmune diseases.
Research-based collaborations are thus driving the antibody discovery market opportunities.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest antibody discovery market analysis, North America held the largest share of monoclonal antibody discovery landscape in 2023 and the scenario is expected to persist during the forecast period.
This is attributed to advancement in infrastructure routed toward discovery of antibodies. In June 2023, AbTherx announced that it had launched Atlas Mice, its transgenic mouse-based antibody discovery platform.
Asia Pacific’s noticeable antibody discovery market growth is due to new product launch by the companies based in this region.
For instance, in June 2023, Sanyou Biopharmaceuticals introduced Sanyou Super Trillion Common Light Chain Antibody Discovery Platform that expends support to discovery of the bispecific antibody formats.
The companies involved in discovery of antibodies are engaged in organic as well as inorganic modes of expansion to increase their footprint.
For instance, in October 2023, F. Hoffmann-La Roche Ltd. inked a definitive agreement for acquiring Televant with the purpose of receiving manufacturing, development, and commercialization rights in Japan and the U.S. for Televant’s TL1A directed antibody called RVT-3101.
In December 2022, AbbVie Inc. strategically collaborated with HotSpot Therapeutics to license the agreement for the latter’s discovery-stage IRF5 program to treat autoimmune diseases.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Evotec A.G., Sartorius AG, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Bruker Cellular Analysis, Inc., BioDuro LLC, Aragen Life Sciences, Abzena, AbTherx, and Sanyou Biopharmaceuticals Co., Ltd. are some of the key players covered in the antibody discovery market report.
These players have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.6 Bn |
| Market Forecast (Value) in 2034 | US$ 4.8 Bn |
| Growth Rate (CAGR) | 10.1% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.6 Bn in 2023
It is projected to advance at a CAGR of 10.1% from 2024 to 2034
Rise in advancements in antibody engineering and increase in frequency of collaboration of pharmaceutical companies with academic institutions
Pharmaceutical and biotechnology companies accounted for the largest share in 2023
North America was the dominant region in 2023
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Evotec A.G., Sartorius AG, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Bruker Cellular Analysis, Inc., BioDuro LLC, Aragen Life Sciences, Abzena, AbTherx, Sanyou Biopharmaceuticals Co., Ltd., and other prominent players
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Antibody Discovery Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Antibody Discovery Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Antibody Discovery Market Analysis and Forecast, by Antibody Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Antibody Type, 2020-2034
6.3.1. Monoclonal
6.3.2. Polyclonal
6.3.3. Others
6.4. Market Attractiveness Analysis, by Antibody Type
7. Global Antibody Discovery Market Analysis and Forecast, by Service
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Service, 2020-2034
7.3.1. Phage Display
7.3.2. Hybridoma
7.3.3. Others
7.4. Market Attractiveness Analysis, by Service
8. Global Antibody Discovery Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.2. Research Laboratories
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Antibody Discovery Market Analysis and Forecast, by Region
9.1. Introduction
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Region, 2020-2034
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
10. North America Antibody Discovery Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Antibody Type, 2020-2034
10.3.1. Monoclonal
10.3.2. Polyclonal
10.3.3. Others
10.4. Market Value Forecast, by Service, 2020-2034
10.4.1. Phage Display
10.4.2. Hybridoma
10.4.3. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Pharmaceutical and Biotechnology Companies
10.5.2. Research Laboratories
10.5.3. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Antibody Type
10.7.2. By Service
10.7.3. By End-user
10.7.4. By Country
11. Europe Antibody Discovery Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Antibody Type, 2020-2034
11.3.1. Monoclonal
11.3.2. Polyclonal
11.3.3. Others
11.4. Market Value Forecast, by Service, 2020-2034
11.4.1. Phage Display
11.4.2. Hybridoma
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Pharmaceutical and Biotechnology Companies
11.5.2. Research Laboratories
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Antibody Type
11.7.2. By Service
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Antibody Discovery Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Antibody Type, 2020-2034
12.3.1. Monoclonal
12.3.2. Polyclonal
12.3.3. Others
12.4. Market Value Forecast, by Service, 2020-2034
12.4.1. Phage Display
12.4.2. Hybridoma
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Pharmaceutical and Biotechnology Companies
12.5.2. Research Laboratories
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Antibody Type
12.7.2. By Service
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Antibody Discovery Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Antibody Type, 2020-2034
13.3.1. Monoclonal
13.3.2. Polyclonal
13.3.3. Others
13.4. Market Value Forecast, by Service, 2020-2034
13.4.1. Phage Display
13.4.2. Hybridoma
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Pharmaceutical and Biotechnology Companies
13.5.2. Research Laboratories
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Antibody Type
13.7.2. By Service
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Antibody Discovery Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Antibody Type, 2020-2034
14.3.1. Monoclonal
14.3.2. Polyclonal
14.3.3. Others
14.4. Market Value Forecast, by Service, 2020-2034
14.4.1. Phage Display
14.4.2. Hybridoma
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Pharmaceutical and Biotechnology Companies
14.5.2. Research Laboratories
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Antibody Type
14.7.2. By Service
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Evotec A.G.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Sartorius AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Charles River Laboratories International, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Creative Biolabs, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Bruker Cellular Analysis, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. BioDuro LLC
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Aragen Life Sciences
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Abzena
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. AbTherx
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Sanyou Biopharmaceuticals Co., Ltd.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Other Prominent Players
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 02: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 03: Global Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 07: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 08: North America Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 11: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 12: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 15: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 16: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 19: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 20: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034
Table 23: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034
Table 24: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Antibody Discovery Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Antibody Discovery Market Revenue (US$ Bn), by Antibody Type, 2023
Figure 03: Global Antibody Discovery Market Value Share, by Antibody Type, 2023
Figure 04: Global Antibody Discovery Market Revenue (US$ Bn), by Service, 2023
Figure 05: Global Antibody Discovery Market Value Share, by Service, 2023
Figure 06: Global Antibody Discovery Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Antibody Discovery Market Value Share, by End-user, 2023
Figure 08: Global Antibody Discovery Market Value Share, by Region, 2023
Figure 09: Global Antibody Discovery Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 11: Global Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 13: Global Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 14: Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Antibody Discovery Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Antibody Discovery Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Antibody Discovery Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 22: North America Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 23: North America Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 26:North America Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 31: Europe Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 32: Europe Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 35: Europe Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 40: Asia Pacific Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 41: Asia Pacific Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 44: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 49: Latin America Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 50: Latin America Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 53: Latin America Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034
Figure 58: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034
Figure 59: Middle East & Africa Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034
Figure 62: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Antibody Discovery Market
*86 figures and 60 tables includes